Donald A. Britt
Chief Quality Officer, Executive Vice President an
Executive
Tanvex BioPharma, Inc.
United States of America
Biography
Mr. Britt serves as the President of Britt Pharmaceutical Consulting. He serves as the Senior Vice President of Corporate Quality Assurance at Actavis Pharma, Inc. He has over 40 years of experience in the pharmaceutical industry, primarily in the Quality and Regulatory affairs disciplines. After Abbott, he became Manufacturing Manager for Bayer Biologics. Mr. Britt served as the Senior Vice President of Quality Assurance at Allergan plc (alternate name, Actavis, Inc.) since August 2000. He is Other Professional at Actavis Pharma Inc. He served as an Executive Vice President of Corporate Quality Assurance at Aptuit LLC (alternate name, Aptuit, Inc.). Previously, he served Schein Pharmaceutical Inc. as its Senior Vice President, Quality and Regulatory Affairs from January 2000 to August 2000. From May 1999 through January 2000, Mr. Britt served as Senior Vice President Quality Assurance and Quality Control and Compliance for Centocor, Inc. From February 1996 to May 1999, he was initially Vice President of World Wide Quality for Rhone-Poulenc Rorer, Inc. and subsequently named Vice President for World Wide Quality and Health, Safety and Environment for Aventis S.A. He served as Senior Vice President of Global Quality and EH&S for Aventis Pharma, Senior Vice President of Global Quality for Centocor Biologics, and Senior Vice President of Global Quality for Watson (Actavis). Mr. Britt held various positions of increasing responsibility within the Quality function at GlaxoSmithKline. He serves as a Director of Avara Pharmaceutical Services
Research Interest
Biochemistry and Microbiology,Quality Assurance and Quality Control and Compliance